Basing on uPAR-binding fragment to design chimeric antigen receptors triggers antitumor efficacy against uPAR expressing ovarian cancer cells.
Biomed Pharmacother
; 117: 109173, 2019 Sep.
Article
in En
| MEDLINE
| ID: mdl-31387176
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Receptors, Chimeric Antigen
/
Membrane Proteins
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Biomed Pharmacother
Year:
2019
Document type:
Article